Utomilumab

• Description :

  Utomilumab (PF 05082566) is a fully human IgG2 agonist monoclonal antibody that selectively binds to 4-1BB/CD137. Utomilumab can be used in the research of tumors such as follicular and other CD20+ non-Hodgkin lymphomas[1][2][3].

• CAS Number :

  [1417318-27-4]

• Product Name Alternative :

  PF 05082566

• UNSPSC :

  12352203

• Target :

  TNF Receptor

• Type :

  Inhibitory Antibodies

• Related Pathways :

  Apoptosis

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Cancer; Inflammation/Immunology

• Assay Protocol :

  https://www.medchemexpress.com/utomilumab.html

• Purity :

  99.90

• Solubility :

  H2O

• Smiles :

  [Utomilumab]

• Molecular Weight :

  (142.78 kDa)

• References & Citations :

  +

• Shipping Conditions :

  Dry Ice

• Storage Conditions :

  Store at -80°C for 2 years

• Scientific Category :

  Inhibitory Antibodies

• Clinical Information :

  Phase 3

• Isoform :

  TNFRSF9/4-1BB/CD137